A bipartisan trio of senators on Monday introduced a resolution underscoring their opposition to the experiments last year in China that led to the birth of the world’s first genome-edited babies
Quick Read
After a two-year stint running the Food and Drug Administration, Scott Gottlieb has joined the board of directors at Pfizer, giving the world’s largest drug maker crucial insights into the inner workings of the Trump administration as it attempts to contain national angst over the rising cost of medicines
Quick Read
While these findings regarding professionalism are disturbing, they do point toward another way in which fraudulent stem cell clinics can be stopped, said Alan Regenberg, at the Johns Hopkins Berman Institute of Bioethics
Quick Read
Be the first to like. Like Unlike
Quick Read
Africa’s Science Academy Leads Push for Ethical Data UseJune 18, 2019 |
The goal is to create the continent’s first cross-disciplinary guidelines for collecting, storing and sharing data and specimens
Quick Read
Backers of Maryland’s stem cell ecosystem hope a federal judge’s ruling last week in a Florida case that the Food and Drug Administration can regulate stem cell treatments is the first step toward protecting their legitimacy. With comments from our Debra Mathews
Quick Read
The agency said two patients received donated stool that had not been screened for drug-resistant germs, leading it to halt clinical trials until researchers prove proper testing procedures are in place
Quick Read
Hiding in Plain SightJune 5, 2019 |
Peter Lurie writes, “The FDA’s approach to disclosing new drug applications is a disservice to public health”
Quick Read